400-921-8278
| Catalog_no | ADMC0774 |
| Product_name | Cariprazine (RGH-188) |
| Category | 抑制剂与激动剂 |
| Size | 10mg/50mg/100mg |
| Price | 2220.00/7220.00/10560.00 |
| Specificity | Target: Dopamine Receptor. Fields: Cariprazine (RGH-188) is a novel putative antipsychotic drug that exerts partial agonism at dopamine D2/D3 receptors, with preferential binding to D3 receptors, and partial agonism at serotonin 5-HT1A receptors. Ki: |
| Dilution | Ki: 0.49 nM (D2 receptor), 0.085 nM (D3 receptor), 2.6 nM (5-HT1A receptor)[1] |
| Purification | 99.80% |
| Concentration | 靶点：Dopamine Receptor;IC50：Ki: 0.49 nM (D2 receptor), 0.085 nM (D3 receptor), 2.6 nM (5-HT1A receptor)[1] |
| Storage_stability | 2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername | RGH 188;Cariprazine;RGH188,RGH-188 |
| Observed_band | 463.9 |
| Notes | Cariprazine (RGH-188) is a novel putative antipsychotic drug that exerts partial agonism at dopamine D2/D3 receptors, with preferential binding to D3 receptors, and partial agonism at serotonin 5-HT1A receptors. Ki: 0.49 nM (D2 receptor), 0.085 nM (D |
| Instructions | 
查看与下载 |
| Share |
 |
Copyright © 2021 苏州博特龙免疫技术有限公司 版权所有 ，苏ICP备2021013855号-1
苏公网安备32050702011981号 
